JPY 162.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.35 Billion JPY | 32.38% |
2022 | 3.28 Billion JPY | 52.98% |
2021 | 2.15 Billion JPY | 14.67% |
2020 | 1.87 Billion JPY | 4.63% |
2019 | 1.79 Billion JPY | 4.86% |
2018 | 1.7 Billion JPY | -1.1% |
2017 | 1.72 Billion JPY | 4.73% |
2016 | 1.64 Billion JPY | 30.44% |
2015 | 1.26 Billion JPY | 100.37% |
2014 | 631.27 Million JPY | 38.32% |
2013 | 456.37 Million JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.15 Billion JPY | 1.76% |
2023 Q3 | 1.11 Billion JPY | 5.39% |
2023 FY | 4.35 Billion JPY | 32.38% |
2023 Q1 | 1.04 Billion JPY | 14.21% |
2023 Q4 | 1.13 Billion JPY | 1.79% |
2023 Q2 | 1.05 Billion JPY | 1.24% |
2022 FY | 3.28 Billion JPY | 52.98% |
2022 Q3 | 831 Million JPY | 5.06% |
2022 Q4 | 915 Million JPY | 10.11% |
2022 Q2 | 791 Million JPY | 5.33% |
2022 Q1 | 751 Million JPY | -6.48% |
2021 Q4 | 803 Million JPY | 54.13% |
2021 Q2 | 445 Million JPY | 17.11% |
2021 Q3 | 521 Million JPY | 17.08% |
2021 FY | 2.15 Billion JPY | 14.67% |
2021 Q1 | 380 Million JPY | -39.49% |
2020 FY | 1.87 Billion JPY | 4.63% |
2020 Q3 | 453 Million JPY | 4.14% |
2020 Q1 | 359 Million JPY | -31.88% |
2020 Q2 | 435 Million JPY | 21.17% |
2020 Q4 | 628 Million JPY | 38.63% |
2019 Q4 | 527 Million JPY | 19.23% |
2019 Q2 | 430 Million JPY | 9.41% |
2019 Q1 | 393 Million JPY | -17.26% |
2019 FY | 1.79 Billion JPY | 4.86% |
2019 Q3 | 442 Million JPY | 2.79% |
2018 Q2 | 417 Million JPY | 24.48% |
2018 Q3 | 482 Million JPY | 15.59% |
2018 Q4 | 475 Million JPY | -1.45% |
2018 FY | 1.7 Billion JPY | -1.1% |
2018 Q1 | 335 Million JPY | -40.65% |
2017 Q1 | 353.17 Million JPY | -40.6% |
2017 FY | 1.72 Billion JPY | 4.73% |
2017 Q4 | 564.46 Million JPY | 40.41% |
2017 Q3 | 402 Million JPY | -1.47% |
2017 Q2 | 408 Million JPY | 15.52% |
2016 Q2 | 328.99 Million JPY | 20.98% |
2016 Q4 | 594.6 Million JPY | 30.85% |
2016 Q3 | 454.41 Million JPY | 38.12% |
2016 Q1 | 271.93 Million JPY | -27.53% |
2016 FY | 1.64 Billion JPY | 30.44% |
2015 FY | 1.26 Billion JPY | 100.37% |
2015 Q4 | 375.21 Million JPY | 12.13% |
2015 Q3 | 334.61 Million JPY | -13.2% |
2015 Q2 | 385.48 Million JPY | 127.32% |
2015 Q1 | 169.58 Million JPY | -39.87% |
2014 Q3 | 137.05 Million JPY | 19.92% |
2014 Q1 | 97.92 Million JPY | -47.52% |
2014 FY | 631.27 Million JPY | 38.32% |
2014 Q4 | 282.02 Million JPY | 105.78% |
2014 Q2 | 114.28 Million JPY | 16.71% |
2013 FY | 456.37 Million JPY | 0.0% |
2013 Q4 | 186.58 Million JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
DVx Inc. | 45.85 Billion JPY | 90.504% |
Seikagaku Corporation | 36.21 Billion JPY | 87.977% |
Eiken Chemical Co., Ltd. | 40.05 Billion JPY | 89.129% |
Create Medic Co., Ltd. | 12.58 Billion JPY | 65.404% |
PHC Holdings Corporation | 353.9 Billion JPY | 98.77% |
Techno Medica Co., Ltd. | 10.28 Billion JPY | 57.662% |
Rion Co., Ltd. | 25.72 Billion JPY | 83.076% |
Nihon Kohden Corporation | 221.98 Billion JPY | 98.039% |
Fukuda Denshi Co., Ltd. | 140.32 Billion JPY | 96.897% |
Japan Lifeline Co., Ltd. | 51.38 Billion JPY | 91.527% |
Japan Medical Dynamic Marketing, INC. | 23.17 Billion JPY | 81.215% |
3-D Matrix, Ltd. | 4.58 Billion JPY | 5.117% |